Anil Sood
Molecular Biology · 2005–2018
A researcher in the Science corpus: 17 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 326 citations into it
- Cancer Research — 227 citations into it
Whom Anil Sood trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Carlo Maria Croce (in Cancer Research)
- John J. Rossi (in Molecular Biology)
- Gregory J. Hannon (in Molecular Biology)
- George A. Calin (in Cancer Research)
Papers from Anil Sood's perspective
Ordered by how strongly the researchers Anil Sood trusts endorse each paper. Same corpus, a different order for every researcher.
- Expression profiling reveals off-target gene regulation by RNAi
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells (Nature Cell Biology)
- MicroRNA gene expression deregulation in human breast cancer. (Cancer Research)
- The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution (Science)
- Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival (Cancer Research)
- Prediction of mammalian microRNA targets. (Cell)
- Nuclear Export of MicroRNA Precursors (Science)
- Argonaute2 Is the Catalytic Engine of Mammalian RNAi (Science)
- A microRNA expression signature of human solid tumors defines cancer gene targets (Proceedings of the National Academy of Sciences of the United States of America)
- Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. (Molecules and Cells)
Their papers
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) — 792 citations
- Integrated Genomic Analyses of Ovarian Carcinoma (2011) — 7,559 citations
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) — 2,007 citations
- MicroRNAs in body fluids—the mix of hormones and biomarkers (2011) — 1,453 citations
- Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. (2005) — 681 citations
- Pathogenic germline variants in 10,389 adult cancers (2018) — 734 citations
- The Immune Landscape of Cancer (2018) — 4,752 citations
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) — 2,663 citations
- Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer (2015) — 1,071 citations
- Advances and Challenges of Liposome Assisted Drug Delivery (2015) — 2,224 citations
- Comprehensive Genomic Characterization of Long Non-Coding RNAs across Human Cancers (2015) — 606 citations
- Paraneoplastic Thrombocytosis in Ovarian Cancer (2012) — 757 citations
- Rethinking Ovarian Cancer: Recommendations for Improving Outcomes (2011) — 1,276 citations
- RNA interference in the clinic: challenges and future directions (2010) — 819 citations
- Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer (2008) — 740 citations
- Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma (2006) — 1,286 citations
- The influence of bio-behavioural factors on tumour biology: pathways and mechanisms (2006) — 989 citations